1) Design and synthesis of new ligands as allosteric agonist for
M1- muscarinic receptor subtypes.
2) Design and synthesis of new multipotent ligands acting as
anticancer.
3) Design and synthesis of new multipotent ligands in the
treatment of neurodegenerative disorders.
4) Polyamines as substrates and inhibitors of amino-oxidase
enzymes.
